AAAAAA
Results:
1-15
|
Results: 15
Authors:
Lansbury, PT
Citation: Pt. Lansbury, Following nature's anti-amyloid strategy, NAT BIOTECH, 19(2), 2001, pp. 112-113
Authors:
Conway, KA
Rochet, JC
Bieganski, RM
Lansbury, PT
Citation: Ka. Conway et al., Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct, SCIENCE, 294(5545), 2001, pp. 1346-1349
Authors:
Volles, MJ
Lee, SJ
Rochet, JC
Shtilerman, MD
Ding, TT
Kessler, JC
Lansbury, PT
Citation: Mj. Volles et al., Vesicle permeabilization by protofibrillar alpha-synuclein: Implications for the pathogenesis and treatment of Parkinson's disease, BIOCHEM, 40(26), 2001, pp. 7812-7819
Authors:
Goldberg, MS
Lansbury, PT
Citation: Ms. Goldberg et Pt. Lansbury, Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?, NAT CELL BI, 2(7), 2000, pp. E115-E119
Authors:
Fezoui, Y
Hartley, DM
Harper, JD
Khurana, R
Walsh, DM
Condron, MM
Selkoe, DJ
Lansbury, PT
Fink, AL
Teplow, DB
Citation: Y. Fezoui et al., An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments, AMYLOID, 7(3), 2000, pp. 166-178
Authors:
Lansbury, PT
Kosik, KS
Citation: Pt. Lansbury et Ks. Kosik, Neurodegeneration: new clues on inclusions, CHEM BIOL, 7(1), 2000, pp. R9-R12
Authors:
Rochet, JC
Lansbury, PT
Citation: Jc. Rochet et Pt. Lansbury, Amyloid fibrillogenesis: themes and variations, CURR OP STR, 10(1), 2000, pp. 60-68
Authors:
Conway, KA
Lee, SJ
Rochet, JC
Ding, TT
Williamson, RE
Lansbury, PT
Citation: Ka. Conway et al., Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy, P NAS US, 97(2), 2000, pp. 571-576
Authors:
Rochet, JC
Conway, KA
Lansbury, PT
Citation: Jc. Rochet et al., Inhibition of fibrillization and accumulation of prefibrillar oligomers inmixtures of human and mouse alpha-synuclein, BIOCHEM, 39(35), 2000, pp. 10619-10626
Authors:
Conway, KA
Harper, JD
Lansbury, PT
Citation: Ka. Conway et al., Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid, BIOCHEM, 39(10), 2000, pp. 2552-2563
Authors:
Lansbury, PT
Citation: Pt. Lansbury, Yeast prions: Bungee cord domains' balancing act, CURR BIOL, 9(22), 1999, pp. R845-R847
Authors:
Lansbury, PT
Citation: Pt. Lansbury, Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease, P NAS US, 96(7), 1999, pp. 3342-3344
Authors:
Koo, EH
Lansbury, PT
Kelly, JW
Citation: Eh. Koo et al., Amyloid diseases: Abnormal protein aggregation in neurodegeneration, P NAS US, 96(18), 1999, pp. 9989-9990
Authors:
Zhen, W
Han, H
Anguiano, M
Lemere, CA
Cho, CG
Lansbury, PT
Citation: W. Zhen et al., Synthesis and amyloid binding properties of rhenium complexes: Preliminaryprogress toward a reagent for SPECT imaging of Alzheimer's disease brain, J MED CHEM, 42(15), 1999, pp. 2805-2815
Authors:
Harper, JD
Wong, SS
Lieber, CM
Lansbury, PT
Citation: Jd. Harper et al., Assembly of A beta amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease, BIOCHEM, 38(28), 1999, pp. 8972-8980
Risultati:
1-15
|